Medication info

Empagenta 10/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tabletLinagliptin›5mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pale yellow triangular film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202503120 · Approved 2025.11.28

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching from concomitant empagliflozin and linagliptin therapy to this medicine should take the doses they were previously receiving. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose as scheduled. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients No dose adjustment is required based on age. In patients aged 75 years and older, consider renal function and the risk of volume depletion.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medicine is used to help patients with type 2 diabetes control their blood sugar levels. It is most effective when taken together with dietary and exercise therapy, as Empagliflozin and Linagliptin work together to aid in improving blood sugar levels. This supports treatment for individuals who find it difficult to manage their blood sugar.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching from concomitant empagliflozin and linagliptin therapy to this medicine should take the doses they were previously receiving. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose as scheduled. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients No dose adjustment is required based on age. In patients aged 75 years and older, consider renal function and the risk of volume depletion.

Precautions

This medication consists of two components, Empagliflozin and Linagliptin, and is primarily used for diabetes treatment. First, this medication should not be taken by those who are allergic to Empagliflozin, Linagliptin, or other ingredients in the medication. Additionally, it should not be used by patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. This medication contains lactose, so individuals with genetic metabolic disorders such as lactose intolerance or galactose intolerance should avoid taking it. Patients with reduced kidney function may experience decreased effectiveness of this medication, so it is important to regularly check kidney function before and after administration. Those with heart disease associated with kidney failure should also exercise caution, and it is not recommended for patients with severe heart failure. Due to the presence of Linagliptin, acute pancreatitis may occur; thus, if severe abdominal pain or other symptoms of pancreatitis arise, the medication should be stopped immediately and a doctor consulted. Additionally, a rare skin condition known as bullous pemphigoid may occur, so if blisters or skin irritation appear, medical personnel should be informed immediately. The most common side effect of this medication is urinary tract infection, and genital infections may also occur. Symptoms of hypoglycemia may arise, so caution is needed, especially when taken with blood sugar-lowering agents like insulin or sulfonylureas. Due to potential fluid loss, blood pressure may drop; therefore, individuals with hypotension or cardiovascular disease should use this medication carefully, and if dehydration is suspected, the medication may need to be temporarily discontinued. Elderly patients, particularly those over 75, should be more cautious due to the increased risk of fluid loss and hypotension. Women who are pregnant or planning to become pregnant are advised not to use this medication, and nursing mothers are also recommended to discontinue breastfeeding during treatment. Children under 18 years of age should not use this medication, as its safety and efficacy have not been established for this age group. Furthermore, this medication may have mild effects when driving or operating machinery; therefore, caution is necessary to reduce the risk of hypoglycemia, particularly when taken with blood sugar-lowering agents. Lastly, if this medication is taken together with insulin or sulfonylureas, there may be an increased risk of hypoglycemia, so dosage adjustments may be necessary. When taken with diuretics, there is an increased risk of dehydration and hypotension, so consultation with medical personnel is essential. When storing this medication, keep it out of reach of children and store it in its original container for safety.

Side effects

  • Urinary tract infection
  • Vulvovaginitis
  • Vulvitis
  • Balanitis
  • Genital infection
  • Hypersensitivity
  • Angioedema
  • Urticaria
  • Hypoglycemia
  • Thirst
Show 195 more
  • Ketoacidosis
  • Cough
  • Constipation
  • Pancreatitis
  • Oral ulcer formation
  • Itching
  • Rash
  • Vesicular pemphigoid
  • Rhabdomyolysis
  • Blood volume depletion
  • Increased urination
  • Urinary difficulties
  • Interstitial nephritis
  • Increased amylase
  • Increased lipase
  • Increased hematocrit
  • Increased serum lipids
  • Increased blood creatinine
  • Decreased glomerular filtration rate
  • Upper abdominal pain
  • Enterocolitis
  • Intestinal obstruction
  • Gastroenteritis
  • Shingles
  • Cystitis
  • Acute pyelonephritis
  • Bronchitis
  • Vestibular neuritis
  • Septicemia
  • Pneumonia
  • Decreased appetite
  • Dehydration
  • Hyperglycemia
  • Cerebral infarction
  • Speech disorders
  • Alzheimer's dementia
  • Chest pain
  • Fever
  • Facial edema
  • Fatigue
  • Death
  • Chronic obstructive pulmonary disease
  • Asthma
  • Diabetic foot
  • Skin lesions
  • Acute kidney injury
  • End-stage renal disease
  • Acute cholangitis
  • Acute cholecystitis
  • Cholangitis
  • Dizziness
  • Vascular stent stenosis
  • Vascular stent thrombosis
  • Headache
  • Vomiting
  • Diarrhea
  • Gastritis
  • Gastroesophageal reflux disease
  • Burning mouth syndrome
  • Colitis
  • Abdominal discomfort
  • Dysphagia
  • Gastric ulcer
  • Gum bleeding
  • Tooth loss
  • Hemorrhoids
  • Lower abdominal pain
  • White tongue syndrome
  • Rhinitis
  • Soft tissue infection
  • Pharyngitis
  • Rickettsial disease
  • Periodontitis
  • Tonsillitis
  • Laryngitis
  • Viral upper respiratory infection
  • Tonsillitis
  • Positional dizziness
  • Sensory loss
  • Perception abnormalities
  • Amnesia
  • Carotid stenosis
  • Facial paralysis
  • Drowsiness
  • CNS-origin vertigo
  • Peripheral edema
  • Facial swelling
  • Peripheral swelling
  • Facial swelling
  • Edema
  • Pain at the puncture site
  • Vascular stent stenosis
  • Vascular stent thrombosis
  • Weight gain
  • ECG abnormalities
  • Decreased hemoglobin
  • Increased hemoglobin
  • Helicobacter test positive
  • Urine hematuria positive
  • Ureteral stones
  • Hematuria
  • Renal mass
  • Urinary retention
  • Abnormal urination
  • Benign prostatic hyperplasia
  • Erectile dysfunction
  • Atrophic vulvovaginitis
  • Cervicitis
  • Vaginal discharge
  • Hypoglycemia
  • Obesity
  • Acromegaly
  • Hyperlipidemia
  • Hyponatremia
  • Vitamin D deficiency
  • Dermal cysts
  • Seborrheic dermatitis
  • Atopic dermatitis
  • Nummular eczema
  • Heat rash
  • Sebaceous gland hyperplasia
  • Lumbar spinal canal stenosis
  • Myalgia
  • Limb pain
  • Musculoskeletal chest pain
  • Arthralgia
  • Cervical stenosis
  • Fibromyalgia
  • Flank pain
  • Fracture pain
  • Muscle weakness
  • Osteoarthritis
  • Osteoporosis
  • Rotator cuff syndrome
  • Astigmatism
  • Cataract
  • Allergic conjunctivitis
  • Blurred vision
  • Corneal erosion
  • Macular fibrosis
  • Eye discomfort
  • Ocular congestion
  • Pathological myopia
  • Retinal detachment
  • Retinal crystals
  • Retinal vein occlusion
  • Exudative retinal detachment
  • Eyelid swelling
  • Visual impairment
  • Vitreous floaters
  • Vitreous hemorrhage
  • Epistaxis
  • Age-related dyspnea
  • Productive cough
  • Allergic rhinitis
  • Residual sputum
  • Skin laceration
  • Rib fracture
  • Iliolumbar ligament syndrome
  • Angina
  • Palpitations
  • Prinzmetal angina
  • Coronary artery disease
  • Tachycardia
  • Arteriosclerosis
  • Deep vein thrombosis
  • Diabetic angiopathy
  • Peripheral artery occlusive disease
  • Anxiety
  • Depression
  • Sleep disorders
  • Acute cholecystitis
  • Autoimmune hepatitis
  • Cholelithiasis
  • Hepatitis
  • Otalgia
  • Positional vertigo
  • Dizziness
  • Anemia
  • Lymphadenopathy
  • Hypothyroidism
  • Thyroid mass
  • Constipation
  • Chest discomfort
  • Chest pain
  • Weakness
  • Weight loss
  • Vulvar pruritus
  • Genital pruritus
  • Dyslipidemia
  • Cough
  • Dyspnea
  • Unstable angina
  • Hypertension
  • Insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is also recommended to store the medicine at room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow triangular film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.